Abstract

This presentation will focus on the challenges associated with applying PDT as a theranostic modality for complex disease. Intricacies associated with formulation and drug delivery, dosimetry, and combination therapies that address cancer-sustaining pathways will be discussed. Article not available.

© 2015 OSA

PDF Article